The Classical subtype of GBM is recognized by epidermal growth factor (EGFR) amplifications, and the overexpression of EGFR has been associated with elevated levels of phosphorylated ERK1/2, possibly indicating increased levels or activity MEK1/241. The gene discussed is EGF; the disease is glioblastoma.